Back

Using empagliflozin for HFpEF treatment - what does this look like in practice?

22 May 2022 (15:10 - 15:25)
Organised by:
Congress Presentation Part of: A new era for HFpEF – Exploring the role of empagliflozin in practice Chronic Heart Failure Open Access Heart Failure 2022

About the speaker

Photo
Doctor Shelley Zieroth

St. Boniface Hospital, Winnipeg (Canada)

3 More presentations in this session

Presentation thumbnail
Welcome and introduction.
Professor A. Stewart Coats (Sydney, AU)
Slides Video
Presentation thumbnail
What is the evidence for empagliflozin in HF?
Professor J. Butler (Dallas, US)
Slides Video
Presentation thumbnail
Panel discussion and close.
Professor A. Stewart Coats (Sydney, AU)
Slides Video

Access the full session

Session thumbnail
A new era for HFpEF – Exploring the role of empagliflozin in practice
Video

The Event

Event poster

Heart Failure 2022

22 May 2022 15:10 CET
You may be interested in
thumbnail
Congress Presentation
Implementing empagliflozin for HFpEF treatment in my practice.
27 August 2022
thumbnail
Congress Presentation
Practical guidance for the use of SGLT2 inhibitors in patients with chronic heart failure across the spectrum of ejection fraction
20 May 2023
thumbnail
Congress Presentation
What value do SGLT2 inhibitors offer to patients hospitalised for heart failure?
26 August 2023
thumbnail
Congress Presentation
What is the evidence for SGLT2 inhibitors in HF?
26 August 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources